[1]
Paul, D. et al. 2025. Pharmacogenomic Profiling of DPYD Mutations and Genotype‑guided Dose Adjustment to Prevent Fluoropyrimidine Toxicity in Gastrointestinal Cancer Patients: A Real‑world Study from North India. Asian Pacific Journal of Cancer Care. 10, 4 (Dec. 2025), 1093–1100. DOI:https://doi.org/10.31557/apjcc.2025.10.4.1093-1100.